INTERCEPT PHARMACEUTICALS, INC. Annual Costs and Expenses in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
  • Intercept Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2023 was $93.4M, a 6.47% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2023 was $379M, a 11.3% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $354M, a 2% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $361M, a 22.1% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $464M, a 17.8% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $354M -$7.23M -2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $361M -$103M -22.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $464M -$101M -17.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $564M +$99.1M +21.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $465M -$1.27M -0.27% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $467M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2015 $232M +$117M +102% Jan 1, 2015 Dec 31, 2015 10-K 2016-02-29
2014 $115M +$73.8M +180% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-29
2013 $41.1M +$19.7M +92.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $21.4M +$5.72M +36.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $15.6M -$718K -4.39% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $16.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.